ENERGY MEDICINE THERAPEUTICS

摘要

The invention in suitable embodiments is directed to energy medicine therapeutic compositions enabled by man-made clathrin proteins. In one aspect, one or more purified clathrin protein, formed in whole or in part from isolated, synthetic and or recombinant amino acid residues comprising in whole or in part one or more clathrin heavy chain protein and isoforms thereof, and including one or more of an element or a material for use in supplying an electrical, an electromagnetic, a photonic, a quantum, or a thermal action or effect to a biological element or a biological process, form one or more type of therapeutic composition for treating a cell process, a genotype or a phenotype disease, condition, or disorder, in vivo or in vitro.

主权项

1. An energy medicine composition for treating a disease, condition, or disorder comprising: at least one of a man made protein comprising a clathrin heavy chain protein amino acid sequence that is stable with respect to dissociation in vivo or in vitro, and the man made sequence further does not comprise adaptor proteins, and the man made sequence further does not self-assemble into a cavity forming clathrin cage or a clathrin coated vesicle at physiological pH, and also including one or more of an element or a material acceptable for binding to any of the clathrin non-cage or clathrin non-coated vesicle protein and for use in supplying an electrical, an electromagnetic, a photonic, a quantum, or a thermal action or effect to a biological element or a biological process, and administering to a subject in need thereof the preceding protein or composition, wherein the disease, condition, or disorder comprises in whole or in part a cell element or a cell process.